Human Tumor Antigens Yesterday, Today, and Tomorrow
Masterful Antibodies: Checkpoint Blockade
Myeloid-Derived Suppressor Cells
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy
Regulatory T Cells: Differentiation and Function
Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
Innate Lymphoid Cells in Cancer
Neoepitopes of Cancers: Looking Back, Looking Ahead
Complete
ARCHIVE for
Masters of Immunology
Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy
Lighting a Fire: Can We Harness Pyroptosis to Ignite Antitumor Immunity?
Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved
Understanding and Overcoming the Inflammatory Toxicities of Immunotherapy
Immune Escape during Breast Tumor Progression
Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies
Harnessing Natural Killer Cell Antitumor Immunity: From the Bench to Bedside
Metabolic Consequences of T-cell Costimulation in Anticancer Immunity
Protective Innate Immune Variants in Racial/Ethnic Disparities of Breast and Prostate Cancer
Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple Myeloma
Pulling RANK on Cancer: Blocking Aire-Mediated Central Tolerance to Enhance Immunotherapy
The Highs and Lows of Immune-Checkpoint Blockade in Lymphoma
Adoptive Immunotherapy with Antigen-Specific T Cells Expressing a Native TCR
Complete ARCHIVE for
Cancer Immunology at the Crossroads